Original story published 2024-09-05 16:02:34
STORY SUMMARY
A recent study published in the Journal of the American Medical Association brings optimistic news for those on the kidney transplant waiting list, recording a significant drop in risk for living kidney donors over the past decade. Analyzing data from 1993 to 2022, the research encompassed over 164,000 living donors, noting a death rate decrease from 36 total deaths to just five in the past ten years. Currently, around 990,000 individuals in the United States await kidney transplants, facing a 3 to 5-year wait time. In Wisconsin alone, approximately 1,200 people are on the waiting list. Dr. Josh Mesich, surgical director of UW Health’s living kidney donation program, elaborated on the advancements that have contributed to reduced risks, highlighting improved donor evaluation, minimally invasive surgical techniques, and widespread adoption of vascular staplers. These advancements have not only enhanced safety but also improved recovery by reducing opioid use and better pain management. This progress is encouraging for both donors and recipients, reinforcing the importance and potential of living kidney donations.
VIDEO
FULL STORY
A recent study published in the Journal of the American Medical Association reveals reassuring news for those on the kidney transplant waiting list. The research, spanning from 1993 to 2022, indicates a significant reduction in the risks associated with living kidney donation over the past decade. Among the 164,000 donors analyzed, 36 deaths were recorded, but only five of these occurred in the last 10 years. This decline in mortality is particularly notable, given the increasing number of hopeful transplant patients – currently around 990,000 in the U.S., with an average wait time of three to five years.
Dr. Josh Mesich, the surgical director of W Health’s living kidney donation program in Wisconsin, discusses how these advancements are a source of optimism within the medical community. He emphasizes the crucial principle of doing no harm, underscoring that the reduction in donor mortality can be attributed to improvements in medical evaluation, surgical techniques, and the widespread use of safer technologies like vascular staplers. Mesich also commends the collective effort within the medical community to refine best practices, contributing to a safer and more efficient donation process.
Recovery for living donors has also improved, thanks to better post-operative care strategies, including minimizing opioid use and focusing on patient education. Dr. Mesich highlights the invaluable contributions of donors, regardless of age, noting that each donation serves as a significant gift of life. The focus on thorough medical and psychological evaluations ensures donors are fully informed and committed, reducing the pressure and potential risks associated with the donation process. This research and ongoing medical advancements enhance the overall experience and outcomes for living donors and recipients alike.
